MARK MCDADE - 05 Jun 2024 Form 4 Insider Report for Tourmaline Bio, Inc. (TRML)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TRML	Stock Option (Right to Buy)	Award	$0	+10,000		$0.000000	10,000	05 Jun 2024	Common Stock	10,000	$13.91	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	100% of the shares subject to the option vest on the earlier of the anniversary of the Transaction Date or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on such vesting date.